Trials / Completed
CompletedNCT01866163
LEO 90100 Compared to Vehicle in Subjects With Psoriasis Vulgaris
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 426 (actual)
- Sponsor
- LEO Pharma · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this trial is to compare the efficacy of treatment with LEO 90100 to that of treatment with vehicle for up to 4 weeks in subjects with psoriasis vulgaris.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LEO 90100 | |
| DRUG | Vehicle |
Timeline
- Start date
- 2013-06-01
- Primary completion
- 2013-10-01
- Completion
- 2013-11-01
- First posted
- 2013-05-31
- Last updated
- 2025-03-10
- Results posted
- 2016-05-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01866163. Inclusion in this directory is not an endorsement.